Skip to main content

datastreet.in

Subscribe
Facebook-f Instagram Twitter Youtube

Dr Lal Path Labs needs volume growth to clear its FY27 tests

Risks remain around pricing pressure in a competitive diagnostics market, continued cost pressures, and execution risks in scaling newer segments

Source :- mint – markets Read More

Share it :

Leave a Reply

Your email address will not be published. Required fields are marked *

Get free tips and resources right in your inbox, along with 10,000+ others

Categories

Latest Post

logo_neonews.png
Subscribe